Sign in

CIK 0000882095 · Large accelerated filer

GILEAD SCIENCES, INC.

Sign in to watch
Ticker
GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943047598
Phone
6505743000
Business address
333 LAKESIDE DR, FOSTER CITY, CA, 94404
Former names
GILEAD SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$35,234,659
in 11 filings, $35.2M under 10b5-1 plans

Net −$35,234,659. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-04-30 WELTERS ANTHONY Director Grant or award · Non-qualified Stock Option (Right to Buy) +4,884 4,884
2026-04-30 LOVE TED W Director Grant or award +1,146 5,484
2026-04-30 LOVE TED W Director Grant or award · Non-qualified Stock Option (Right to Buy) +4,884 4,884
2026-04-30 BARTON JACQUELINE K Director Grant or award +1,146 27,202
2026-04-30 BARTON JACQUELINE K Director Grant or award · Non-qualified Stock Option (Right to Buy) +4,884 4,884
2026-04-30 Bluestone Jeffrey Director Grant or award +1,146 10,066
2026-04-30 Bluestone Jeffrey Director Grant or award · Non-qualified Stock Option (Right to Buy) +4,884 4,884
2026-04-28 O'Day Daniel Patrick Chairman & CEO Sale 10b5-1 −6,950 $128.79 $895K 635,617
2026-04-28 O'Day Daniel Patrick Chairman & CEO Sale 10b5-1 −3,050 $130.01 $397K 632,567
2026-04-15 Mercier Johanna Chief Comm & Corp Aff Officer Sale 10b5-1 −3,000 $140.96 $423K 128,779
2026-04-15 Dickinson Andrew D Chief Financial Officer Sale 10b5-1 −3,000 $140.96 $423K 176,191
2026-03-27 O'Day Daniel Patrick Chairman & CEO Sale 10b5-1 −10,000 $136.82 $1.4M 642,567
2026-03-16 Mercier Johanna Chief Comm & Corp Aff Officer Sale 10b5-1 −3,000 $144.23 $433K 131,779
2026-03-16 Dickinson Andrew D Chief Financial Officer Sale 10b5-1 −3,000 $144.23 $433K 179,191
2026-03-10 Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp Option exercise +1,246 5,660
2026-03-10 Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp Shares withheld for taxes −606 $148.56 $90K 5,054
2026-03-10 Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp Option exercise · Restricted Stock Unit −1,246 15,536
2026-03-10 Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp Grant or award · Restricted Stock Unit +5,050 20,586
2026-03-10 Cain Wettan Keeley M EVP Gen Counsel, Legal & Comp Grant or award · Non-qualified Stock Option (Right to Buy) +18,885 18,885
2026-03-10 Burkhart Erin SVP, Controllership Grant or award · Restricted Stock Unit +2,355 11,245

Page 7 of 30 · 584 trades